Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Synthesis and In Vitro Evaluation of Tetrahydroquinoline Derivatives as Antiproliferative Compounds of Breast Cancer via Targeting the GPER.
Zacarías-Lara OJ, Méndez-Luna D, Martínez-Ruíz G, García-Sanchéz JR, Fragoso-Vázquez MJ, Bello M, Becerra-Martínez E, García-Vázquez JB, Correa-Basurto J. Zacarías-Lara OJ, et al. Among authors: mendez luna d. Anticancer Agents Med Chem. 2019;19(6):760-771. doi: 10.2174/1871520618666181119094144. Anticancer Agents Med Chem. 2019. PMID: 30451119
Modifications on the Tetrahydroquinoline Scaffold Targeting a Phenylalanine Cluster on GPER as Antiproliferative Compounds against Renal, Liver and Pancreatic Cancer Cells.
Méndez-Luna D, Morelos-Garnica LA, García-Vázquez JB, Bello M, Padilla-Martínez II, Fragoso-Vázquez MJ, Dueñas González A, De Pedro N, Gómez-Vidal JA, Mendoza-Figueroa HL, Correa-Basurto J. Méndez-Luna D, et al. Pharmaceuticals (Basel). 2021 Jan 10;14(1):49. doi: 10.3390/ph14010049. Pharmaceuticals (Basel). 2021. PMID: 33435260 Free PMC article.
Selection of a GPER1 Ligand via Ligand-based Virtual Screening Coupled to Molecular Dynamics Simulations and Its Anti-proliferative Effects on Breast Cancer Cells.
Martínez-Muñoz A, Prestegui-Martel B, Méndez-Luna D, Fragoso-Vázquez MJ, García-Sánchez JR, Bello M, Martínez-Archundia M, Chávez-Blanco A, Dueñas-González A, Mendoza-Lujambio I, Trujillo-Ferrara J, Correa-Basurto J. Martínez-Muñoz A, et al. Among authors: mendez luna d. Anticancer Agents Med Chem. 2018;18(11):1629-1638. doi: 10.2174/1871520618666180510121431. Anticancer Agents Med Chem. 2018. PMID: 29745344
N-(2-hydroxyphenyl)-2-propylpentanamide, a valproic acid aryl derivative designed in silico with improved anti-proliferative activity in HeLa, rhabdomyosarcoma and breast cancer cells.
Prestegui-Martel B, Bermúdez-Lugo JA, Chávez-Blanco A, Dueñas-González A, García-Sánchez JR, Pérez-González OA, Padilla-Martínez II, Fragoso-Vázquez MJ, Mendieta-Wejebe JE, Correa-Basurto AM, Méndez-Luna D, Trujillo-Ferrara J, Correa-Basurto J. Prestegui-Martel B, et al. J Enzyme Inhib Med Chem. 2016;31(sup3):140-149. doi: 10.1080/14756366.2016.1210138. Epub 2016 Aug 2. J Enzyme Inhib Med Chem. 2016. PMID: 27483122
Design, in silico studies, synthesis and in vitro evaluation of oseltamivir derivatives as inhibitors of neuraminidase from influenza A virus H1N1.
Neri-Bazán RM, García-Machorro J, Méndez-Luna D, Tolentino-López LE, Martínez-Ramos F, Padilla-Martínez II, Aguilar-Faisal L, Soriano-Ursúa MA, Trujillo-Ferrara JG, Fragoso-Vázquez MJ, Barrón BL, Correa-Basurto J. Neri-Bazán RM, et al. Eur J Med Chem. 2017 Mar 10;128:154-167. doi: 10.1016/j.ejmech.2017.01.039. Epub 2017 Jan 24. Eur J Med Chem. 2017. PMID: 28182988
20 results